Form 8-K - Current report:
SEC Accession No. 0001919246-26-000014
Filing Date
2026-03-19
Accepted
2026-03-19 06:39:22
Documents
42
Period of Report
2026-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pths-20260319.htm   iXBRL 8-K 32898
2 EX-99.1 pths-pressreleasex20250319.htm EX-99.1 170793
3 EX-99.2 companypresentation_2026.htm EX-99.2 32709
7 companypresentation_2026001.jpg GRAPHIC 66427
8 companypresentation_2026002.jpg GRAPHIC 249924
9 companypresentation_2026003.jpg GRAPHIC 119445
10 companypresentation_2026004.jpg GRAPHIC 165952
11 companypresentation_2026005.jpg GRAPHIC 176133
12 companypresentation_2026006.jpg GRAPHIC 51177
13 companypresentation_2026007.jpg GRAPHIC 141358
14 companypresentation_2026008.jpg GRAPHIC 113459
15 companypresentation_2026009.jpg GRAPHIC 175736
16 companypresentation_2026010.jpg GRAPHIC 112418
17 companypresentation_2026011.jpg GRAPHIC 50648
18 companypresentation_2026012.jpg GRAPHIC 81812
19 companypresentation_2026013.jpg GRAPHIC 86533
20 companypresentation_2026014.jpg GRAPHIC 109743
21 companypresentation_2026015.jpg GRAPHIC 87342
22 companypresentation_2026016.jpg GRAPHIC 53017
23 companypresentation_2026017.jpg GRAPHIC 155469
24 companypresentation_2026018.jpg GRAPHIC 54459
25 companypresentation_2026019.jpg GRAPHIC 164466
26 companypresentation_2026020.jpg GRAPHIC 49055
27 companypresentation_2026021.jpg GRAPHIC 106473
28 companypresentation_2026022.jpg GRAPHIC 142224
29 companypresentation_2026023.jpg GRAPHIC 40207
30 companypresentation_2026024.jpg GRAPHIC 122875
31 companypresentation_2026025.jpg GRAPHIC 113531
32 companypresentation_2026026.jpg GRAPHIC 73585
33 companypresentation_2026027.jpg GRAPHIC 159085
34 companypresentation_2026028.jpg GRAPHIC 68152
35 image.jpg GRAPHIC 15435
  Complete submission text file 0001919246-26-000014.txt   4672341

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pths-20260319.xsd EX-101.SCH 1770
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pths-20260319_lab.xml EX-101.LAB 23449
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pths-20260319_pre.xml EX-101.PRE 13573
45 EXTRACTED XBRL INSTANCE DOCUMENT pths-20260319_htm.xml XML 2925
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 26772344
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)